cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2004; 43:2150, doi:10.1016/j.jacc.2004.03.008
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abrams, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abrams, J.

LETTER TO THE EDITOR

Time course of the interaction between tadalafil and nitrates

Jonathan Abrams, MD

Division of Cardiology, University of New Mexico, School of Medicine, Ambulatory Care Building, 5th Floor, 2211 Lomas Boulevard NE, Albuquerque, New Mexico 87131, USA

Jabrams{at}salud.unm.edu


The Express Publication by Kloner et al. (1) on the interactions between nitrates and tadalafil should be of interest to all cardiologists and physicians seeing patients with acute chest pain.

However, I have several questions: 1) What is the duration of erectile dysfunction efficacy of tadalifil? The long half-life suggests that responsiveness to the drug may last 2 to 3 days; do we know whether the blood pressure and heart rate effects of nitrates with tadalafil on board are concordant with the duration of improvement in sexual function? 2) It is unclear whether there is a repeat run-in of 7 days for both placebo and tadalafil after the cross-over, that is, is the second-half dosing the same as the first part of the protocol? 3) Why is the recommendation made to withhold concomitant use of a nitrate and tadalafil for 48 h when all data robustly support no interaction at this time interval? 4) The half-life of sildenafil, the gold standard phosphodiesterase 5 (PDE5) inhibitor is not provided. This would be useful, including the best estimate of its duration of its action, as well as the time period during which there is a potentially hazardous interaction between this PD5 inhibitor and nitrates. 5) Is it possible that an acute dosing interaction (no previous exposure for several days) with nitrates with sildenafil or tadalafil might induce a different response to nitrates than after 5 to 6 consecutive half-lives of the PD5 inhibition? Thus, it may be that a form of tolerance to nitrate hemodynamic effects could develop within days in the vasculature, attenuating the decrease in blood pressure and increase in heart rate after an individual has been taking a PD5 inhibitor for a considerable amount of time, as in this experiment. The protocol design does not really mirror the way sildenafil and tadalafil are used in daily living. It would be useful to know if there are data that answer these questions.


    References
 Top
 References
 

  1. Kloner RA, Hutter AM, Emmick JT, et al. Time course of the interaction between tadalafil and nitrates. J Am Coll Cardiol. 2003;42:1855–1860[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abrams, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abrams, J.

 
  cardiology careers collections past issues search home